Head to Head Review: Exactech (EXAC) vs. SeaSpine Holdings Corporation (SPNE)
Exactech (NASDAQ: EXAC) and SeaSpine Holdings Corporation (NASDAQ:SPNE) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.
Valuation and Earnings
This table compares Exactech and SeaSpine Holdings Corporation’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Exactech||$262.96 million||1.66||$43.51 million||$0.04||761.44|
|SeaSpine Holdings Corporation||$130.35 million||1.00||-$21.74 million||($3.18)||-3.27|
Exactech has higher revenue and earnings than SeaSpine Holdings Corporation. SeaSpine Holdings Corporation is trading at a lower price-to-earnings ratio than Exactech, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
64.6% of Exactech shares are held by institutional investors. Comparatively, 39.0% of SeaSpine Holdings Corporation shares are held by institutional investors. 28.3% of Exactech shares are held by company insiders. Comparatively, 14.6% of SeaSpine Holdings Corporation shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Volatility and Risk
Exactech has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, SeaSpine Holdings Corporation has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500.
This is a breakdown of recent ratings and recommmendations for Exactech and SeaSpine Holdings Corporation, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|SeaSpine Holdings Corporation||0||0||3||0||3.00|
SeaSpine Holdings Corporation has a consensus price target of $18.50, suggesting a potential upside of 77.88%. Given SeaSpine Holdings Corporation’s higher possible upside, analysts clearly believe SeaSpine Holdings Corporation is more favorable than Exactech.
This table compares Exactech and SeaSpine Holdings Corporation’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|SeaSpine Holdings Corporation||-27.90%||-32.86%||-24.72%|
Exactech beats SeaSpine Holdings Corporation on 10 of the 12 factors compared between the two stocks.
Exactech Company Profile
Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.
SeaSpine Holdings Corporation Company Profile
SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip and extremities procedures.
Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.